Coeptis Therapeutics, Inc. Long-Term Debt, Maturity, Year Four
Coeptis Therapeutics, Inc. had Long-Term Debt, Maturity, Year Four of $2.08 thousand as of 2022-06-30, per its 10-Q filed 2022-08-02.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2022-11-08
- 2022-06-30: Long-Term Debt, Maturity, Year Four $2.08K.
- 2022-03-31: Long-Term Debt, Maturity, Year Four $2.18K.
- 2021-12-31: Long-Term Debt, Maturity, Year Four $0.00; Long-Term Debt, Maturity, Year Four as first filed $2.18K.
- 2021-09-30: Long-Term Debt, Maturity, Year Four $8.68K.
| Period end | Long-Term Debt, Maturity, Year Four | Long-Term Debt, Maturity, Year Four as first filed |
|---|---|---|
| 2022-06-30 | $2.08K 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $2.18K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 | $2.18K 10-K · filed 2022-03-11 |
| 2021-09-30 | $8.68K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $8.68K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $8.68K 10-Q/A · filed 2021-05-18 |